Vaccine Overview
Leuprolide Acetate 3.75 mg USP
Leuprolide Acetate 3.75 mg is a gonadotropin-releasing hormone (GnRH) agonist used in the management of hormone-sensitive conditions such as prostate cancer, endometriosis, and uterine fibroids. It works by reducing levels of testosterone or estrogen, leading to a temporary hormonal suppression. Administered via injection, Leuprolide helps control disease progression or symptoms. Side effects may include hot flashes, mood swings, and decreased bone density. Patients should be closely monitored during treatment by a healthcare professional.
Drug Class: Pharma Products
Indication: Hormone-sensitive cancers, fibroid shrinkage, endometriosis
PREVENTS
Vaccine Details
Applied To
Infants, Children, Adolescents, Adults
Recommended Time
Monthly (injection)
Administration
Route: Parenteral (Injection)
Site: Subcutaneous or intramuscular (typically thigh, buttock, or abdomen)
Disease
Prostate cancer, endometriosis, fibroids
Manufacturer
Serum Intitute Of India
Age
- Adults
Disclaimer
This information is provided for educational purposes only and should not replace professional medical advice. Always consult with a healthcare professional before getting vaccinated or if you have any concerns about vaccines or side effects.
Last updated: May 2, 2025